March 11 (Reuters) – The U.S. Food and Drug Administration said on Wednesday it has introduced a unified platform designed to streamline the analysis of reports on drug side effects.
(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)
Comments